510(k) device
Inomax DSIR
Mallinckrodt Manufacturing, LLC · Apparatus, Nitric Oxide Delivery (MRN, Class II) · First FDA decision Apr 20, 2023, newest Apr 20, 2023Respiratory failure and ventilation
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
0
Naming "Inomax DSIR"
MAUDE reports
1,473
Brand "Inomax DSIR", since 2015
PubMed studies
0
Mentioning "Inomax DSIR"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Inomax DSIR
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Inomax DSIR510(k)
K211153 · Decided Apr 20, 2023 · 731 days after receipt
Device type: Apparatus, Nitric Oxide Delivery (MRN) · Anesthesiology & Respiratory
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Inomax DSIR", any status and sponsor, newest update first.
No registered device study names "Inomax DSIR".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Inomax DSIR", and for the whole product code for context.
This brand
1,473 reports: 1,416 malfunction, 40 injury, 8 death
Whole product code MRN
1,689 reports: 1,573 malfunction, 91 injury, 15 death
Newest reports for this brand
- INOmax DSIR Plus (Delivery System)Malfunction
Mallinckrodt Manufacturing LLC
3004531588-2026-00050 · Received Oct 7, 2026 · Event dated Mar 31, 2025
Device type: Apparatus, Nitric Oxide Delivery (MRN)
Device problem as coded: Failure to Deliver
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Inomax DSIR"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code MRN.
- Inomax Ds (Delivery System)Ino Therapeutics · 510(k) 2012
- ULSPIRA TS Nitric Oxide Therapy SystemAirgas Therapeutics, LLC · 510(k) 2026
- NOxBOXi Nitric Oxide Delivery SystemLinde Gas & Equipment, Inc. · 510(k) 2024
- EVOLVE Nitric Oxide Delivery SystemMallinckrodt Manufacturing, LLC · 510(k) 2025
- Inomax Dsir (Delivery System)Ino Therapeutics · 510(k) 2013
- EVOLVE Nitric Oxide Delivery SystemMalinckrodt Manufacturing, LLC · 510(k) 2024
- The NOxBOXi Nitric Oxide Delivery SystemPraxair, Inc. · 510(k) 2020
- INOmax DSIR PlusMallinckrodt Manufacturing, LLC · 510(k) 2020
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.